Self-injected drug may ease pain for migraine sufferers

A self-injected smart drug holds out new hope for migraine sufferers who until now have had to grit their teeth and bear the pain of thunderclap headaches.

Trial results show that the antibody drug erenumab can cut episodic migraine attacks by more than half in a large proportion of cases.